Online Course
24
Nov
2023
2023
25
Nov
2023
2023
Molecular Diagnostics, Genomics in Cancer Online Course 2023
Chairs
Matti Aapro, CH – Joseph Gligorov, FR – Frederique Penault-Llorca, FR
Date
Friday 24 and Saturday 25 November 2023
Background
Following the success of the course "Molecular Diagnostics, Genomics in Breast Cancer 2021", which had more than 2200 registrations and 700 participants connected live from more than 100 countries, SPCC is pleased to propose a second edition in 2023 focusing on:
• Breast Cancer: pathology, molecular and multigene testing, clinical decision making with tests and clinical case discussion
• Other Cancers: markers for tailored treatment and clinical discussion on applicability and guidance from experts with live audience discussion
Learning Objectives
• Improving care for patients with breast and other cancers
• Discussing recent updates in molecular diagnostics in breast and other cancers
• Discussing recent updates in molecular diagnostics in breast and other cancers
• Practicing thanks to case discussions with experts
Target Group
Geneticists - Pathologists - Clinical Oncologists - Medical Oncologists - Haemato-Oncologists - Surgeons - Nurses - Patient Advocates – Radiologists – Epidemiologists - Molecular Biologists
Course Format
The course, consisting of 2 consecutive days of live sessions, will be held online with the participation of world-renowned experts.
It will be free of charge and can be accessed by registering on SPCC's OncoCorner e-learning platform. The material will remain available on-demand.
Continuing Medical Education accreditation
Application for CME accreditation has been submitted to the Accreditation Council of Oncology in Europe (ACOE).
The programme was recognised as being of high quality from both a scientific and didactic point of view and was awarded 5 CME credits.
Participants will be issued a certificate of attendance (minimum attendance: 75% of the entire course). An online evaluation questionnaire and learning assessment test will need to be completed in order to get the certificate that will be issued by email.
Acknowledgements
Sharing Progress in Cancer Care wishes to express its appreciation to Exact Sciences, Novartis and Veracyte for their support with unconditional educational grants.
Supporters have no input into speakers, the agenda or content for the programme.
Supporters have no input into speakers, the agenda or content for the programme.
24/11/2023 15:00 CET
DAY 1 - Breast and gynaecological cancer
24/11/2023 15:00 CET
Welcome and introduction
Chair: Aapro Matti, CH
Chair: Gligorov Joseph, FR
Chair: Penault-Llorca Frederique, FR
24/11/2023 15:05 CET
How much information can we gain from classical pathology?
Expert: Salgado Roberto, BE
24/11/2023 15:25 CET
Molecular and multigene testing in early breast cancer – where do we stand?
Expert: Penault-Llorca Frederique, FR
24/11/2023 15:45 CET
Molecular gynaecological pathway: ovarian carcinoma with HRD, endometrial carcinoma with MSI HER2, and PD-L1 cervical carcinoma
Expert: Matias-Guiu Guia Xavier, ES
24/11/2023 16:05 CET
Clinical decision-making assisted by molecular/multigene testing in early breast cancer
Expert: Harbeck Nadia, DE
24/11/2023 16:25 CET
Educational sessions discussion and Q&A
Chair: Aapro Matti, CH
Chair: Gligorov Joseph, FR
Chair: Penault-Llorca Frederique, FR
Expert: Matias-Guiu Guia Xavier, ES
Expert: Salgado Roberto, BE
24/11/2023 16:50 CET
Groups Session: Patient Cases discussion on Early Breast Cancer
Case 1: woman 29 years old
Case 2: woman 73 years old
Case 3: woman 45 years old
Case 4: woman 55 years old
Case 2: woman 73 years old
Case 3: woman 45 years old
Case 4: woman 55 years old
Expert: Al Sukhun Sana, JO
Expert: Cardoso Maria-João, PT
Expert: El Saghir Nagi S., LB
Expert: Kaidar-Person Orit, IL
Expert: Machiels Melanie, BE
Expert: Pruneri Giancarlo, IT
Expert: Rubio Isabel T., ES
Expert: Salgado Roberto, BE
Moderator: Gligorov Joseph, FR
Moderator: Harbeck Nadia, DE
25/11/2023 15:00 CET
DAY 2 - Other cancers
25/11/2023 15:00 CET
Welcome and introduction
Chair: Aapro Matti, CH
Chair: Gligorov Joseph, FR
Chair: Penault-Llorca Frederique, FR
25/11/2023 15:05 CET
Thyroid Cancer; what to ask for in order to give the appropriate treatment (if available)
Expert: Ryška Aleš, CZ
25/11/2023 15:25 CET
Educational session discussion and Q&A
Chair: Aapro Matti, CH
Chair: Gligorov Joseph, FR
Chair: Penault-Llorca Frederique, FR
Expert: Ryška Aleš, CZ
25/11/2023 15:45 CET
Lung Cancer; what to ask for in order to give the appropriate treatment (if available)
Expert: Lopez-Rios Fernando, ES
25/11/2023 16:05 CET
Educational session discussion and Q&A
Chair: Aapro Matti, CH
Chair: Gligorov Joseph, FR
Chair: Penault-Llorca Frederique, FR
Discussant: Noronha Vanita, IN
Discussant: Rolfo Christian, US
Expert: Lopez-Rios Fernando, ES
25/11/2023 16:25 CET
Colorectal Cancer; what to ask for in order to give the appropriate treatment (if available)
Expert: Svrcek Magali, FR
25/11/2023 16:45 CET
Educational session discussion and Q&A
Chair: Aapro Matti, CH
Chair: Gligorov Joseph, FR
Chair: Penault-Llorca Frederique, FR
Discussant: Van Cutsem Eric, BE
Expert: Svrcek Magali, FR
25/11/2023 17:05 CET
Closure
Aapro Matti
Sharing Progress in Cancer Care and Clinique de Genolier, Bellinzona and Genolier, Switzerland
Al Sukhun Sana
Al Hyatt Oncology Practice, Amman, Jordan
Cardoso Maria-João
Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal
El Saghir Nagi S.
American University of Beirut Medical Center, Beirut, Lebanon
Gligorov Joseph
Hospital Tenon Ap-Hp, Paris, France
Harbeck Nadia
Breast Center, LMU University Hospital, Munich, Germany
Kaidar-Person Orit
Sheba Medical Center, Ramat Gan, Israel
Lopez-Rios Fernando
Department of Pathology at "12 de Octubre" University Hospital, Madrid, Spain
Machiels Melanie
Radiation Oncologist at Iridium Netwerk, University of Antwerp, Wilrijk, Belgium
Matias-Guiu Guia Xavier
University of Barcelona, Barcelona, Spain
Noronha Vanita
Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India
Penault-Llorca Frederique
Jean Perrin Center, Clermont-Ferrand, France
Pruneri Giancarlo
IRCCS National Cancer Institute, Milan, Italy
Rolfo Christian
The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, Mount Sinai Health System, New York, USA
Rubio Isabel T.
Clínica Universidad de Navarra, Madrid, Spain
Ryška Aleš
Charles University Medical Faculty Hospital, Hradec Kralove, Czech Republic
Salgado Roberto
GZA Hospitals, Antwerp, Belgium
Svrcek Magali
Sorbonne University, Paris, France
Van Cutsem Eric
University of Leuven, Leuven, Belgium
BREAST CANCER
COLON / RECTAL / COLORECTAL CANCER
GENERAL INTEREST
GYNAECOLOGICAL CANCERS
LUNG CANCER
PATHOLOGY
THYROID CANCER